Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism.

Lu H, Zhang Y, Qiu D, Xie Z, Wang Z, Liu J, Zhang Y

Open source

DOI
10.1016/j.ejphar.2026.179035
Published
2026 Jul 10
Container
European journal of pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179035,
  title = {Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism.},
  author = {Lu H and Zhang Y and Qiu D and Xie Z and Wang Z and Liu J and Zhang Y},
  year = {2026},
  journal = {European journal of pharmacology},
  doi = {10.1016/j.ejphar.2026.179035},
  url = {https://doi.org/10.1016/j.ejphar.2026.179035}
}

RIS

TY  - JOUR
TI  - Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism.
AU  - Lu H
AU  - Zhang Y
AU  - Qiu D
AU  - Xie Z
AU  - Wang Z
AU  - Liu J
AU  - Zhang Y
PY  - 2026
JO  - European journal of pharmacology
DO  - 10.1016/j.ejphar.2026.179035
UR  - https://doi.org/10.1016/j.ejphar.2026.179035
ER  - 

APA

H, L., Y, Z., D, Q., Z, X., Z, W., J, L., & Y, Z. (2026). Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179035

Source records